Vertex Pharmaceuticals Inc (VRTX)
418.10
+0.60
(+0.14%)
USD |
NASDAQ |
Mar 28, 16:00
418.39
+0.29
(+0.07%)
After-Hours: 20:00
Vertex Pharmaceuticals Shareholders Equity (Quarterly): 17.58B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 17.58B |
September 30, 2023 | 16.51B |
June 30, 2023 | 15.47B |
March 31, 2023 | 14.43B |
December 31, 2022 | 13.91B |
September 30, 2022 | 13.03B |
June 30, 2022 | 11.93B |
March 31, 2022 | 10.91B |
December 31, 2021 | 10.10B |
September 30, 2021 | 9.531B |
June 30, 2021 | 9.196B |
March 31, 2021 | 8.980B |
December 31, 2020 | 8.687B |
September 30, 2020 | 8.133B |
June 30, 2020 | 7.519B |
March 31, 2020 | 6.462B |
December 31, 2019 | 6.085B |
September 30, 2019 | 5.253B |
June 30, 2019 | 5.070B |
March 31, 2019 | 4.723B |
December 31, 2018 | 4.435B |
September 30, 2018 | 2.906B |
June 30, 2018 | 2.686B |
March 31, 2018 | 2.401B |
December 31, 2017 | 2.029B |
Date | Value |
---|---|
September 30, 2017 | 1.791B |
June 30, 2017 | 1.671B |
March 31, 2017 | 1.500B |
December 31, 2016 | 1.157B |
September 30, 2016 | 1.022B |
June 30, 2016 | 981.35M |
March 31, 2016 | 957.08M |
December 31, 2015 | 939.97M |
September 30, 2015 | 922.15M |
June 30, 2015 | 894.96M |
March 31, 2015 | 976.46M |
December 31, 2014 | 1.075B |
September 30, 2014 | 1.156B |
June 30, 2014 | 1.172B |
March 31, 2014 | 1.231B |
December 31, 2013 | 1.356B |
September 30, 2013 | 1.265B |
June 30, 2013 | 1.322B |
March 31, 2013 | 746.12M |
December 31, 2012 | 999.18M |
September 30, 2012 | 1.028B |
June 30, 2012 | 1.038B |
March 31, 2012 | 930.50M |
December 31, 2011 | 786.84M |
September 30, 2011 | 579.76M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.723B
Minimum
Mar 2019
17.58B
Maximum
Dec 2023
10.18B
Average
9.364B
Median
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 6.232B |
Eli Lilly and Co | 10.77B |
Regeneron Pharmaceuticals Inc | 25.97B |
Moderna Inc | 13.85B |
Merck & Co Inc | 37.58B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 22.73B |
Total Liabilities (Quarterly) | 5.150B |
Current Ratio | 3.987 |